‘Don’t push into pain!’ How to rescue your knees from everything from torn ligaments to injured tendons
From runner’s knee to fraying cartilage, knees are involved in 40% of sports injuries. But it can be hard to pin down what’s wrong, or what to do about it. Just because knee issues are common, that doesn’t mean we should ignore them and soldier on.
Preoperative Function Affects Ability to Achieve One-Year Minimum Clinically Important Difference for Patients Undergoing Total Knee Arthroplasty
Minimum clinically important difference (MCID) values are commonly used to measure treatment success for total knee arthroplasty (TKA). MCID values vary according to calculation methodology, and prior studies have shown that patient factors are associated with failure to achieve MCID thresholds. The purpose of this study was to determine if anchor-based 1-year Knee Injury and Osteoarthritis Outcome Score Joint Replacement (KOOS-JR) MCID values varied among patients undergoing TKA based on patient-specific factors.
Should You Worry About Joints Cracking or Popping?
Cracking and popping joints, medically known as crepitus, are normal. Joints are points in your body where two bones meet. You might occasionally hear your knees popping or notice your back or bones crack as you move them.
Arthroscopic iliopsoas fractional lengthening may be preferred vs. revision THA
In this video from the Arthroscopy Association of North America Annual Meeting, Mario Hevesi, MD, PhD, discussed arthroscopic lengthening of the iliopsoas tendon following total hip arthroplasty for patients with tendonitis.
Intra-articular injection of bone marrow aspirate concentrate (mesenchymal stem cells) in KL grade III and IV knee osteoarthritis: 4 year results of 37 knees
Cell based therapies are increasingly used and results of bone marrow aspirate concentrate (BMAC) show encouraging short- to middle term results, superior to hyaluronic acid and platelet rich plasma (PRP). Most studies describe patients with mild to moderate arthritis and results of patients with KL III and IV osteoarthritis of the knee are limited to short term evaluations. Hence, the aim of this prospective study was to investigate the mid-term outcome of BMAC injections in patients with severe osteoarthritis of the knee.
